JP2024524433A5 - - Google Patents
Info
- Publication number
- JP2024524433A5 JP2024524433A5 JP2023580804A JP2023580804A JP2024524433A5 JP 2024524433 A5 JP2024524433 A5 JP 2024524433A5 JP 2023580804 A JP2023580804 A JP 2023580804A JP 2023580804 A JP2023580804 A JP 2023580804A JP 2024524433 A5 JP2024524433 A5 JP 2024524433A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- formula
- solvates
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163215818P | 2021-06-28 | 2021-06-28 | |
| US63/215,818 | 2021-06-28 | ||
| PCT/US2022/035336 WO2023278464A1 (en) | 2021-06-28 | 2022-06-28 | Pharmacological agents for preventing and treating cataracts and presbyopia eye diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524433A JP2024524433A (ja) | 2024-07-05 |
| JP2024524433A5 true JP2024524433A5 (enExample) | 2025-07-03 |
Family
ID=84692077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580804A Pending JP2024524433A (ja) | 2021-06-28 | 2022-06-28 | 白内障および老眼眼疾患を予防および治療するための薬理学的薬剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240327439A1 (enExample) |
| EP (1) | EP4362923A4 (enExample) |
| JP (1) | JP2024524433A (enExample) |
| CN (2) | CN116963727A (enExample) |
| CA (1) | CA3225704A1 (enExample) |
| MX (1) | MX2024000116A (enExample) |
| WO (1) | WO2023278464A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11872236B2 (en) | 2018-04-05 | 2024-01-16 | Calasia Pharmaceuticals, Inc. | Pharmacological agents for treating ocular diseases |
| WO2022104383A1 (en) * | 2020-11-13 | 2022-05-19 | Plex Pharmaceuticals, Inc. | Pharmacological agents for treating conditions of the eye |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID19540A (id) * | 1997-01-22 | 1998-07-23 | Hoffmann La Roche | Metode pembuatan turunan-turunan benzofenon |
| US20010044584A1 (en) * | 1997-08-28 | 2001-11-22 | Kensey Kenneth R. | In vivo delivery methods and compositions |
| AU2003243282B2 (en) * | 2002-05-17 | 2008-05-01 | Othera Holding, Inc. | Amelioration of the development of cataracts and other opthalmic diseases |
| WO2014164667A1 (en) * | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
| US9789091B2 (en) * | 2013-03-14 | 2017-10-17 | University Of Massachusetts | Methods of inhibiting cataracts and presbyopia |
| AU2017317129B2 (en) * | 2016-08-24 | 2020-04-30 | National Institute Of Biological Sciences, Beijing | Entacapone-related compounds to treat macular degeneration |
| US11872236B2 (en) * | 2018-04-05 | 2024-01-16 | Calasia Pharmaceuticals, Inc. | Pharmacological agents for treating ocular diseases |
| MX2021014682A (es) * | 2019-05-31 | 2022-04-06 | Plex Pharmaceuticals Inc | Agentes farmacológicos para tratar enfermedades de agregación de proteínas de los ojos. |
| US12523941B2 (en) * | 2020-06-09 | 2026-01-13 | Asml Holding N.V. | Lithographic pre-alignment imaging sensor with build-in coaxial illumination |
| WO2022104383A1 (en) * | 2020-11-13 | 2022-05-19 | Plex Pharmaceuticals, Inc. | Pharmacological agents for treating conditions of the eye |
-
2021
- 2021-11-15 CN CN202180090238.6A patent/CN116963727A/zh active Pending
-
2022
- 2022-06-28 CA CA3225704A patent/CA3225704A1/en active Pending
- 2022-06-28 EP EP22834075.8A patent/EP4362923A4/en not_active Withdrawn
- 2022-06-28 CN CN202280058201.XA patent/CN117915900A/zh active Pending
- 2022-06-28 JP JP2023580804A patent/JP2024524433A/ja active Pending
- 2022-06-28 WO PCT/US2022/035336 patent/WO2023278464A1/en not_active Ceased
- 2022-06-28 MX MX2024000116A patent/MX2024000116A/es unknown
- 2022-06-28 US US18/575,218 patent/US20240327439A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524838A5 (enExample) | ||
| JP2020023528A5 (enExample) | ||
| JP2021528488A5 (enExample) | ||
| JP2020500862A5 (enExample) | ||
| JP2019519598A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2013510825A5 (enExample) | ||
| JP2004531544A5 (enExample) | ||
| RU2002118213A (ru) | Производные адамантана | |
| JP2002526516A5 (enExample) | ||
| JP2019500387A5 (enExample) | ||
| JP2010524947A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2022137237A5 (enExample) | ||
| JP2025507292A5 (enExample) | ||
| JP2023549533A5 (enExample) | ||
| JP2007525494A5 (enExample) | ||
| DK148844C (da) | Analogifremgangsmaade til fremstilling af dihydroxyalkylsubstituerede xanthinderivater | |
| JP2024546678A5 (enExample) | ||
| JP2002525318A (ja) | 眼、耳および鼻治療用の抗生物質組成物 | |
| JP2024542969A5 (enExample) | ||
| JP2023088996A (ja) | 癌治療 | |
| JP2008519788A5 (enExample) | ||
| JP2021505537A5 (enExample) | ||
| RU2007107935A (ru) | Полисульфатированные гликозиды и их соли |